POSITION SUMMARY

The Director of Oncology provides strategic and operational leadership for the practice's oncology service line, overseeing the full continuum of urologic oncology care. This senior-level role is responsible for the development, implementation, and continuous improvement of clinical programs encompassing In-Office Dispensing (IOD), patient navigation, and disease-specific care pathways across Xiaflex treatment, BPH, OAB, bladder cancer, prostate cancer, and radiation therapy. The Director works in close collaboration with physicians, advanced practice providers, administrative leadership, and external partners to ensure exceptional patient outcomes, regulatory compliance, and operational excellence.

Department: Oncology / Urology Service Line

Reports To: Chief Nursing Office

FLSA Status: Exempt

Employment Type: Full-Time

Travel Required: Up to 20% (conferences, vendor meetings, off-site training

KEY RESPONSIBILITIES

In-Office Dispensing (IOD) Program

• Oversee the daily operations and regulatory compliance of the IOD program, including procurement, inventory management, and medication dispensing protocols.

• Ensure adherence to all state pharmacy regulations, DEA requirements, and payer policies governing in-office drug administration.

• Monitor drug utilization trends, reimbursement rates, and financial performance of the IOD program; implement strategies to maximize operational efficiency.

• Partner with billing and coding staff to ensure accurate and timely claims submission for administered medications.

• Maintain vendor relationships with pharmaceutical representatives and group purchasing organizations (GPOs).

Patient Navigation — Xiaflex (Collagenase Clostridium Histolyticum)

• Lead the patient navigation program for Xiaflex, supporting patients diagnosed with Peyronie's disease through the treatment journey from diagnosis through injection series completion.

• Develop and implement standardized workflows for Xiaflex patient identification, prior authorization, scheduling, and follow-up.

• Coordinate closely with urologists and ancillary staff to ensure proper patient selection, informed consent, and post-procedure education.

• Track and report patient outcomes, treatment adherence, and satisfaction metrics for the Xiaflex program.

Benign Prostatic Hyperplasia (BPH)

• Oversee clinical programs and patient navigation for BPH management, including medical therapy, minimally invasive procedures (e.g., UroLift, Rezum, TURP), and surgical referral pathways.

• Support the development of care protocols that align with current AUA guidelines and evidence-based best practices.

• Collaborate with scheduling and care coordination teams to minimize wait times and optimize patient flow for BPH services.

• Monitor quality metrics including symptom score (IPSS) documentation, treatment adherence, and re-treatment rates.

Overactive Bladder (OAB)

• Direct the OAB service line, encompassing conservative management, pharmacotherapy (including IOD of onabotulinumtoxinA), neuromodulation therapy, and advanced treatment referrals.

• Ensure patient navigators provide comprehensive education on treatment options, expected outcomes, and follow-up requirements.

• Track and analyze clinical outcomes data including urinary diary metrics, treatment response rates, and patient-reported quality-of-life measures.

• Facilitate multidisciplinary coordination between urology, urogynecology, and physical therapy as appropriate.

Bladder Cancer Program

• Provide strategic leadership for the bladder cancer care program, covering surveillance, intravesical therapy (BCG, chemotherapy), and navigation for muscle-invasive disease.

• Implement and maintain standardized cystoscopy surveillance schedules and TURBT follow-up protocols in compliance with national guidelines.

• Support navigation for patients requiring cystectomy, systemic chemotherapy, or immunotherapy, ensuring seamless transitions between care settings.

• Coordinate with pathology, radiology, and medical oncology partners to facilitate timely diagnosis and multidisciplinary tumor board participation.

• Manage the IOD program components related to intravesical therapy, including BCG supply chain management and shortage contingency planning.

Prostate Cancer Program

• Lead the comprehensive prostate cancer navigation program, supporting patients from initial PSA screening